Dengue Vaccine Market Trends 2021 | Industry Growth, Size, Share, Demand and Forecast to 2030

In a recent published report, Kenneth Research has updated the market report for Dengue Vaccine Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4  billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Dengue Vaccine Market products.

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10078365

Moreover, the median health expenditure per capita recorded in the high-income, upper-middle income, and low & lower-middle income countries, recorded to be over USD 2,000, USD 400, and USD 100 respectively. Additionally, in the same year, the spending on health in high-income countries and in the low- and middle-income countries comprised approximately 8.2% and 6.3% of the GDP respectively.

“Final Report will add the analysis of the impact of COVID-19 on this industry.”

Recently, a significant growth in healthcare spending have been observed in the low- and middle-income nations. In the middle-income nations, healthcare spending rose by 6.3% a year between 2000 and 2017, while the economy rose by 5.9% a year. Additionally, health spending in low-income countries also observed a growth by 7.8% a year in the same period. The growth in the healthcare spending of these nations can be attributed to the increasing focus of the governments in these nations to meet the laid down targets of the Sustainable Development Goals (SDGs) of 2030. Such factors are anticipated to drive the Dengue Vaccine MARKET during the forecast period.

The Global Dengue Vaccine Market is estimated to grow at a significant rate of 15.6% CAGR from 2017-2025. The main agenda of the report is to provide a global over view of the report and identifying the major hot pockets and revenue centers. The report focuses on the high growth market and provides information on the major trends, drivers, opportunity and threats in the market. the report also provides information on the industry landscape and complete value chain is analyzed. The major focus of the report is also on the competitive landscape wherein the report provides information on Competitive Strategies Adopted by Leading Players, Investments & Expansions, New Product Launches, Mergers & Acquisitions as well as Agreements, Joint Ventures, and Partnerships.

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10078365

The report also provides information on the various regions and analysis the growth covering North America, Europe, Asia Pacific and rest of the world further bifurcated by major countries in these regions.
The major Industry Players in Global Dengue Vaccine Market are GlaxoSmithKline, Merck Sharp & Dohme, Sanofi, Takeda Pharmaceuticals, GeneOne Life Sciences, Medigen Biologics, Panacea Biotec
Sun Pharmaceutical etc. providing information like Company Overview, Financial overview, Product Overview and current development.

By VACCINE TYPE
*Live attenuated vaccines
*Inactivated vaccines

By End User
*Government Institutions
*Hospitals and NGOs

By Region

North America
*USA
*Canada
Europe
*Germany
*U.K.
*France
*Italy
*Rest of Europe
APAC
*China
*India
*Japan
*Rest of Asia-Pacific
RoW
*Latin America
*Middle East & Africa

Table of Content
1. Introduction
1.1 Industry Vision
1.1.1 Industry Definition
1.2 Industry Scope
1.3 Limitations
1.4 Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.1.1. Key Data from Secondary Research
2.1.2. Primary Research
2.1.2.1. Key Data from Primary Research
2.1.2.2. Breakdowns of Primary Interviews
2.2. Industry Size Estimation
2.2.1. Bottoms-Up Approach
2.2.2. Top down Approach
2.2.3. Annual Turnover Process
2.3. Data Triangulation
2.4. Research Assumptions
2.4.1. Assumption
3. Executive Summary
4. Industry Overview
4.1. Introduction
4.2. Strength
4.3. Weakness
4.4. Opportunities
4.5 Threats
4.6 Regulations
4.7 Supply chain analysis/ value chain analysis
4.8 Patents and Standards
5. Industry Trends
5.1 Introduction
5.2 Value Chain Analysis
5.3 Porter’s Five Forces Analysis
5.3.1 Threat of New Entrants
5.3.2 Threat of Substitutes
5.3.3 Bargaining Power of Buyers
5.3.4 Bargaining Power of Suppliers
5.3.5 Intensity of Competitive Rivalry

6. Global Dengue Vaccine Market, By By VACCINE TYPE
6.1 Live attenuated vaccines
6.2 Inactivated vaccines
7. Global Dengue Vaccine Market By End User
7.1 Government Institutions
7.2 Hospitals
7.3 NGOs
8.Geographical Analysis
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. RoE
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. RoAPAC
8.5. RoW
8.5.1. Latin America
8.5.1.1. Brazil
8.5.1.2. Argentina
8.5.1.3. Rest of Latin America
8.5.2. Middle East and Africa
9. Company Profiles
9.1 GlaxoSmithKline
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Overview
9.1.4 Current Development
9.2 Merck Sharp & Dohme
9.3 Sanofi
9.4 Takeda Pharmaceuticals
9.5 GeneOne Life Sciences
9.6 Medigen Biologics
9.7 Panacea Biotec
9.8 Sun Pharmaceutical
10. Competitive Analysis
10.1 Introduction
10.2 Industry Positioning of Key Players
10.3 Competitive Strategies Adopted by Leading Players
10.3.1 Investments & Expansions
10.3.2 New Product Launches
10.3.3 Mergers & Acquisitions
10.3.4 Agreements, Joint Ventures, and Partnerships
11. Appendix
11.1. Questionnaire
11.2 Available Customizations
11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10078365

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609

————————New Related Reports——————————

Surgical Robot Market
Marijuana Market
Diabetes Drugs Market
Fitness Trackers Market
Stem Cell Market
Healthcare AIDC Market
Bone Growth Stimulator Market

Leave a Reply

Your email address will not be published. Required fields are marked *